Evidence map›Paper›PMID 28543773›Full record

ArticleGlia2017

Degradation of heme oxygenase-1 by the immunoproteasome in astrocytes: A potential interferon-γ-dependent mechanism contributing to HIV neuropathogenesis.

Colleen E Kovacsics, Alexander J Gill, Surendra S Ambegaokar, Benjamin B Gelman, Dennis L Kolson

Open access · greenAbstract read
In one paragraph

Article in Glia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Heme oxygenase-1 promoter (GT)Neurology(R) neuroimmunology & neuroinflammation · 2020
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Colleen E KovacsicsDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104.
Alexander J GillDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104.ORCID 0000-0001-8224-9317
Surendra S AmbegaokarDepartment of Botany & Microbiology, Robbins Program in Neuroscience, Ohio Wesleyan University, Delaware, Ohio, 43015.
Benjamin B GelmanDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, 77555.
Dennis L KolsonDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104.
Zero to Three · USOhio Wesleyan University · USThe University of Texas Medical Branch at Galveston · USUniversity of Pennsylvania · US

Funding

East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional ConsortiumU01AI069911 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Leslie Anne Enane, AGGREY SEMWENDERO SEMEERE · 2006 to 2026
$57.7M
Viral Gene Editing and Bioinformatics Core for Institution # 269291P30MH092177 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI Kamel Khalili · 2011 to 2026
$24.9M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
The Manhattan HIV Brain BankU01MH083501 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2008 to 2012
$8.9M
California NeuroAIDS Tissue Network (CNTN)U01MH083506 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2008 to 2012
$8.1M
National Neurological AIDS BankU01MH083500 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2008 to 2012
$7.2M
Texas Repository for AIDS Neuropathogenesis ResearchU01MH083507 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2008 to 2012
$5.1M
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotectionR01MH095671 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ALDOVINI, ANNA, KOLSON, DENNIS LARRY · 2011 to 2015
$3.5M
National NeuroAIDS Tissue Consortium Statistics and Data Coordinating CenterU01MH083545 · NIMH · INDIANA UNIVERSITY INDIANAPOLIS · PI YIANNOUTSOS, CONSTANTIN THEODORE · 2008 to 2012
$3.3M
Regulation of Heme Oxygenase in HIV/HAND PathogenesisR01MH111389 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KOLSON, DENNIS LARRY · 2016 to 2020
$2.9M
TRAINING IN NEUROVIROLOGY AND NEUROIMMUNOLOGYT32NS007180 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 1985 to 2018
$2.8M
NIAID NIH HHS U01 AI069911NIMH NIH HHS F30 MH102120NIMH NIH HHS P30 MH092177NIMH NIH HHS R01 MH095671NIMH NIH HHS R01 MH104134NIMH NIH HHS R01 MH111389NIMH NIH HHS U01 MH083500NIMH NIH HHS U01 MH083501NIMH NIH HHS U01 MH083506NIMH NIH HHS U01 MH083507NIMH NIH HHS U01 MH083545NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100930NINDS NIH HHS R01 NS072005NINDS NIH HHS T32 NS007180
6 · The paper itself

Abstract

Induction of the detoxifying enzyme heme oxygenase-1 (HO-1) is a critical protective host response to cellular injury associated with inflammation and oxidative stress. We previously found that HO-1 protein expression is reduced in brains of HIV-infected individuals with HIV-associated neurocognitive disorders (HAND) and in HIV-infected macrophages, where this reduction associates with enhanced glutamate release and neurotoxicity. Because HIV-infected macrophages are a small component of the cellular content of the brain, the reduction of macrophage HO-1 expression likely accounts for a small portion of brain HO-1 loss in HIV infection. We therefore investigated the contribution of astrocytes, the major pool of brain HO-1. We identified immunoproteasome-mediated HO-1 degradation in astrocytes as a second possible mechanism of brain HO-1 loss in HIV infection. We demonstrate that prolonged exposure of human fetal astrocytes to interferon-gamma (IFNγ), an HIV-associated CNS immune activator, selectively reduces expression of HO-1 protein without a concomitant reduction in HO-1 RNA, increases expression of immunoproteasome subunits, and decreases expression of constitutive proteasome subunits, consistent with a shift towards increased immunoproteasome activity. In HIV-infected brain HO-1 protein reduction also associates with increased HO-1 RNA expression and increased immunoproteasome expression. Finally, we show that IFNγ treatment of astrocytic cells reduces HO-1 protein half-life in a proteasome-dependent manner. Our data thus suggest unique causal links among HIV infection, IFNγ-mediated immunoproteasome induction, and enhanced HO-1 degradation, which likely contribute to neurocognitive impairment in HAND. Such IFNγ-mediated HO-1 degradation should be further investigated for a role in neurodegeneration in inflammatory brain conditions. BRIEF SUMMARY: Kovacsics et al. identify immunoproteasome degradation of heme oxygenase-1 (HO-1) in interferon gamma-stimulated astrocytes as a plausible mechanism for the observed loss of HO-1 protein expression in the brains of HIV-infected individuals, which likely contributes to the neurocognitive impairment in HIV-associated neurocognitive disorders.

Indexed as

Antiviral AgentsAstrocytesCells, CulturedCohort StudiesCysteine Proteinase InhibitorsFemaleFetusHeme Oxygenase-1HIV InfectionsHumansInterferon-gammaLeupeptinsLipopolysaccharidesMaleNAD(P)H Dehydrogenase (Quinone)Prefrontal CortexAntiviral Agentsbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCysteine Proteinase InhibitorsHeme Oxygenase-1Interferon-gammaLeupeptinsLipopolysaccharidesLMP7 proteinNAD(P)H Dehydrogenase (Quinone)NQO1 protein, humanProteasome Endopeptidase ComplexRNAHANDHIV-associated neurocognitive disordersimmunoproteasomeinterferon gamma

Identifiers

PMID28543773
PMCPMC5739592
OpenAlexW2620242306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.